Save the Date: Enhancing paediatric research in Europe through the EU Clinical Trials Regulation Print
Hosted by Glenis Willmott, MEP 
Wednesday, 20th February 2013: 15.00-18.00

European Parliament – Room A3H-1

Rue Wiertz 60, B-1047 Brussels, Belgium

It is widely recognised that the conduct of collaborative clinical trials across multiple Member States has been seriously impeded by the EU Clinical Trials Directive (2001/20/EC) and there is real potential for this to be reversed by the proposed EU Clinical Trials Regulation (CTR).

The most common principal objective of children's cancer trials is treatment optimisation using well-established chemotherapy drugs and the introduction of new, safe and effective innovative medicine in standard care. These trials are non-commercial, sponsored and conducted by academic institutions and funded by public money and/or charity support to cover the trials' organisational structures.

To mark International Childhood Cancer Day, Member of the European Parliament (MEP) and EP Rapporteur of the CTR proposal, Glenis Willmott, will host an event on 20th February 2013 to discuss key issues in the legislation that affect not only paediatric oncology but also other disease areas affecting children and young people. Members of the European Medicines Agency’s European Network for Paediatric Research (EnprEMA)  will join SIOP Europe, the European Society for Paediatric Oncology (SIOPE) to discuss how to enhance and optimise paediatric clinical research through the EU Clinical Trials Regulation.

Places are limited!

Register by filling in the registration form downloadable here and sending it via email at  This e-mail address is being protected from spambots. You need JavaScript enabled to view it / fax to: +32 2 775 02 00.

Registration is on a “first come, first served basis” and deadline for registration is Monday, 11th February 2013.